Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Where Next for AstraZeneca's Dividend?
The Motley Fool
Saturday, January 19, 2013 - 11:13am
tags:
Astra Zeneca, dividend, stock
CORRECTED-UPDATE 2-Lilly drug chosen for US-sponsored Alzheimer's trial
Reuters
Saturday, January 19, 2013 - 11:13am
tags:
Eli Lilly, Alzheimer's disease
Pfizer positions animal IPO
Yahoo/Investors
Saturday, January 19, 2013 - 11:12am
tags:
Pfizer, IPO, Zoetis, stock
J&J Said to Offer Implant Pact That May Reach $2 Billion
Bloomberg
Saturday, January 19, 2013 - 11:09am
tags:
Johnson & Johnson, Implant
Glaxo Accord Said to Spur Lawyer Fight Over Fees
Bloomberg
Saturday, January 19, 2013 - 11:08am
tags:
GlaxoSmithKline, lawsuit, legal
Dendreon's Critical Clinical Trials
The Motley Fool
Saturday, January 19, 2013 - 11:08am
tags:
Dendreon, clinical trials
Big Pharma Diabetes Face-Off
The Motley Fool
Saturday, January 19, 2013 - 11:07am
tags:
Pharma, diabetes, Bristol-Myers Squibb, Astra Zeneca, Novo Nordisk, GlaxoSmithKline
Flu Crisis Prompts Broadest Vaccine Redesign Since 1981
Bloomberg
Friday, January 18, 2013 - 10:50am
tags:
vaccines, Flu
ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A
Bloomberg
Friday, January 18, 2013 - 10:23am
tags:
ThromboGenics, Jetrea, M&A, vitreomacular adhesion
YM Biosciences says ISS, Glass Lewis endorse Gilead deal
The Fly on the Wall
Friday, January 18, 2013 - 10:22am
tags:
YM BioSciences, Gilead, M&A
FDA fast tracks two new lung cancer drugs
PM Live
Friday, January 18, 2013 - 10:17am
tags:
fast track, FDA, Boehringer Ingelheim, Astellas, Roche, Afatinib, Tarceva, non-small cell lung cancer
Forest Labs says Canadian regulators approved its high blood pressure drug Bystolic
Yahoo/AP
Friday, January 18, 2013 - 10:15am
tags:
Forest Labs, Canada, antihypertensives, Bystolic
Why This Pharma is Set for a Great 2013
Motley Fool
Friday, January 18, 2013 - 10:14am
tags:
Sanofi
Cubist Pharmaceuticals Inc Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Friday, January 18, 2013 - 10:14am
tags:
earnings, Cubist Pharmaceuticals
EU agency backs Pfizer leukemia drug
Reuters
Friday, January 18, 2013 - 10:13am
tags:
Europe, Pfizer, Bosulif, leukemia
Pharma's Reputation Continues to Suffer -- What Can Be Done To Fix It?
Forbes
Friday, January 18, 2013 - 10:10am
tags:
pharma industry
Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug
Bloomberg
Friday, January 18, 2013 - 10:09am
tags:
Par Pharmaceutical, generics, Duexis, Horizon Pharma
NuPathe Wins U.S. FDA Approval for Migraine Skin Patch
Bloomberg
Friday, January 18, 2013 - 9:21am
tags:
NuPathe, FDA, migraines, Zecuity
The Biggest Loser in the Obesity Drug Market
Motley Fool
Friday, January 18, 2013 - 9:20am
tags:
obesity, Vivus, Qsymia, Belviq, Arena Pharmaceuticals, Orexigen, Contrave
Shifts in Roche's Top Brass
Yahoo/Zacks.com
Friday, January 18, 2013 - 9:19am
tags:
Roche

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.